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Background
The natriuretic peptides (NPs) atrial NP (ANP), B-type
NP (BNP) and C-type NP (CNP) elicit cellular effects by
binding to transmembrane proteins with guanylyl cyclase
(GC) activity, referred to as GC-A (representing the com-
mon receptor for ANP and BNP) and GC-B (the CNP
receptor). GC-A and GC-B are structurally closely related
proteins with very similar cDNA-deduced molecular
masses in the range of 115 kDa, but their native molecu-
lar weights are significantly (by up to 20 kDa) higher due
to glycosylation.
Differential glycosylation of cell surface receptors can
affect folding, trafficking, ligand binding and/or agonist-
induced signal transduction. Moreover, specific temporal
expression patterns of carbohydrate structures are fre-
quently involved in developmental processes. Hitherto,
however, the glycosylation states of GC-A and GC-B in
vivo are largely unknown, since currently available data
are based to a great extent on studies with receptor-trans-
fected cell lines.
This investigation aimed to characterize the sizes and
posttranslational modifications of native GC-A and GC-
B in different tissues of adult rats and mice. Based on
increasing evidence for specific activities of NPs and
their receptors in the developing brain (1-3), we exam-
ined the glycosylation of GC-A and GC-B during post-
natal brain development.
Methods and results
Western blot (as well as receptor/ligand crosslinking)
experiments and treatments with carbohydrate-digest-
ing enzymes served to investigate the sizes and
posttranslational modifications of the two receptors.
Due to marked tissue-specific differences in N-linked
glycosylation, mean apparent molecular masses of both
rat and mouse GC-A range from 119 kDa in brain to
values between 124 (lung) and 132 (heart) kDa in per-
ipheral tissues. The reduced glycosylation in brain
seems to be central nervous system (CNS)-specific,
since the pituitary, which contains both CNS and
CNS-unrelated tissue, co-expresses the CNS-typical
(119 kDa, reference: olfactory bulb) and the peripheral
(up to 130 Da) forms of GC-A.
GC-B sizes differed in the same manner between periph-
eral organs, indicating equal tissue-dependent influences
on oligosaccharide processing at GC-A and GC-B. A
higher (by 3 kDa) total amount of N-linked carbohydrates
suggests usage of an additional consensus N-glycosylation
site (7 instead of 6 in the case of GC-A). The existence of
region-specific GC-B size variants in cerebellum and olfac-
tory bulb discriminates this receptor from GC-A in the
adult brain.
Both GC-A and GC-B (but not two other glycosylated
membrane proteins examined) are hyperglycosylated at
N-linked sites during early postnatal brain development.
At postnatal day 1, the vast majority of GC-B (but not
GC-A) contain additionally an O-linked carbohydrate
modification.
Affinity labelling and membrane GC assays did not
reveal marked glycoform-associated effects on ligand
binding or agonist-induced cGMP production.
Conclusion
The data uncover tissue-, development- and receptor-
specific glycosylation states. Functional consequences
remain to be elucidated. * Correspondence: hans-dieter.mueller@anatomie.med.uni-giessen.de
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